Collaborators

CDC

 

The Centers for Disease Control and Prevention (CDC) has awarded PrimeVax with the exclusive use rights of the wild type strain of dengue virus used in the PV-001 therapy. Our dengue strain is unique in that its history shows zero confirmed dengue deaths. This strain was selected by Dr. Duane Gubler, D.Sc., a leading dengue researcher and former director of the CDC Fort Collins, Colorado Infectious Disease Laboratory.  

 

http://www.cdc.gov/

© 2020 PrimeVax Immuno-Oncology

PrimeVax